Advertisement

Topics

PE Corporation-Celera Genomics Company Profile

21:16 EST 19th November 2017 | BioPortfolio

The Celera Genomics Group is engaged principally in integrating advanced technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. The Celera Genomics Group's businesses are its online information business and its therapeutic discovery business.

The online information business is a leading provider of information based on the human genome and related biological and medical information. Pharmaceutical, biotechnology, and academic customers use this information, along with customized information technology solutions provided by Celera, to enhance their capabilities in the fields of life science research and pharmaceutical and diagnostic discovery and development.

Location

45 West Gude Drive
Rockville
MD
20850
United States of America

Contact

Phone: +1 240 453 3000
Fax: +1 240 453 4000


News Articles [410 Associated News Articles listed on BioPortfolio]

Recognitions for Contributions in Genomics by Dan David Prize Awards

Recognitions for Contributions in Genomics by Dan David Prize Awards Reporter: Aviva Lev-Ari, PhD, RN   The Source for this List is a Search for “Genomics” on the Dan David Prize webs...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

FILM: What Next for Genomics?

This film documents the Progress Educational Trust/Genomics England event 'What Next for Genomics? Providing Answers, Changing Lives, Transforming the NHS', which launched the Chief Medical Officer's ...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Pricing of $2.73 Million Financing

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / August 4, 2017 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and ac...

Famed Genomics Pioneer's Synthetic Genomics Hit With Gender Discrimination Lawsuit by Former VP

  Life Sciences Jobs   ...

Combination Of BioNano Genomics And 10X Genomics Data Produces High Quality Mammalian Genome At Low Cost

  Life Sciences Jobs   ...

PubMed Articles [198 Associated PubMed Articles listed on BioPortfolio]

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

Synthetic genomics: the art of design and synthesis.

Benefited from the rapid development of high-throughput sequencing, genome editing, DNA synthesis and functional genomics, synthetic genomics gains the momentum in this century. The entire genomes of ...

Equity in international health research collaborations in Africa: Perceptions and expectations of African researchers.

Africa is currently host to a number of international genomics research and biobanking consortia, each with a mandate to advance genomics research and biobanking in Africa. Whilst most of these consor...

"I don't believe it." Acceptance and skepticism of genetic health information among African-American and White smokers.

Effective translation of genomics research into practice depends on public acceptance of genomics-related health information.

Clinical Trials [68 Associated Clinical Trials listed on BioPortfolio]

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

Inflammatory Genomics in Human Carotid Artery Disease

To investigate the relationship between genetic variation in genes for inflammation and carotid artery atherosclerosis.

A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.

Dopamine (DA) plays a critical role in nicotine (and other) addiction and this drug is known to release DA in brain areas mediating reward and motivational processes. Although imaging stud...

Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology

This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injur...

Companies [564 Associated Companies listed on BioPortfolio]

PE Corporation-Celera Genomics

The Celera Genomics Group is engaged principally in integrating advanced technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborat...

Celera Genomics

Celera is engaged principally in integrating high throughput technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera ...

Celera Corporation

Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary ...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Applera Corporation

Our mission is to improve human health and society by understanding and applying the power of biology to develop breakthrough research technologies and diagnostic products.Applera Corporation consists...

More Information about "PE Corporation-Celera Genomics" on BioPortfolio

We have published hundreds of PE Corporation-Celera Genomics news stories on BioPortfolio along with dozens of PE Corporation-Celera Genomics Clinical Trials and PubMed Articles about PE Corporation-Celera Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PE Corporation-Celera Genomics Companies in our database. You can also find out about relevant PE Corporation-Celera Genomics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record